Improved diagnostic and therapeutic options for patients living with ulcerative colitis and atopic dermatitis: this is the ultimate aim of the ImmUniverse project.

New insights into disease severity and progression will enable personalised therapy for each individual patient.


ImmUniverse is an ambitious multi-national research project aimed to improve diagnostic and therapeutic solutions for two immune-mediated diseases: ulcerative colitis (in which the immune system attacks the colon), and atopic dermatitis (which affects the skin). The Regenerative Technologies Lab is part of the project developing innovative ultrasonic stimulation technologies and software models for performing a “wireless biopsy” (non-invasive) for a personalized diagnosis in patients with ulcerative colitis.

More info @


Humanitas University, Italy

AIT Austrian Institute of Technology GmbH, Austria

Istituto Superiore di Sanità (Italian NIH), Italy

Christian-Albrechts-Universität zu Kiel, Germany

University of Cambridge, UK

Amsterdam UMC – Academic Medical Centre Amsterdam, The Neetherlands

Vlaams Instituut voor Biotechnologie (Flemish Institute for Biotechnology), Belgium

Katholieke Universiteit Leuven, Belgium

Ludwig-Maximilian University, Germany

Aarhus University, Austria

Aarhus University Hospital, Austria

University of Luxembourg, Luxembourgh

Joanneum Research Forschungsgesellschaft mbH, Austria

Radboud University Medical Center, Radboudumc, The Neetherlands

Centre Hospitalier Régional Universitaire Nancy, France

Information Technology for Translational Medicine S.A., Luxembourgh

European Patients’ Forum, Germany

European Federation of Allergy and Airways Diseases Patients’ Associations

European Federation of Crohn’s and Ulcerative Colitis Associations, The Neetherlands

European Research and Project Office GmbH, Germany

Sant’Anna School of Advanced Studies, Italy

GlaxoSmithKline Research and Development Ltd., UK

Sanofi-Aventis Deutschland GmbH, Germany

Eli Lilly and Company Limited, UK

Novartis Pharma AG, Switzerland

Pfizer Ltd, UK